News & Updation
Best Paper Awards
World Journal of Advance Healthcare Research (WJAHR)Honored the authors with best paper award, monthly based on the innovation of research work. Best paper will be selected by our expert panel.
Best Article of current issue
Download Article : Click here
NOVEL COVID 19: A GLOBAL PANDEMIC
Dr. D. S. R. S. Prakash*
The term ?Epidemic? means ?a sudden outbreak of infectious disease that spreads rapidly through the population, affecting a large proportion of people?. Similarly ?Pandemic? is a technical word used to indicate ?an epidemic so widely spread that vast number of people globally more than 200 countries are affected?. These two words cause panic among the common citizen, cause extra ordinary alertness in the administration and raise brain storming situation among the researchers and scientists. In such situations the health workers have to stand as the soldiers to fight for the administration. They have to forget food, rest and sleep. Public co-operation is must to overcome such situations successfully. ?COVID-19? the situation caused by the dreadful virus ?CORONA? is now standing as the great challenge for the human society. Life of the citizen is in danger irrespective of age, sex, religion, caste , financial condition and profession. Starting from China it has already caused havoc in the developed countries and now affecting India. A novel coronavirus disease (COVID-19), triggered by infection with SARS-CoV-2, has flounced across 31 provinces in China and more than 200 countries worldwide globally. The transition from first symptoms to acute respiratory distress syndrome (ARDS) is extremely probable to be due to unrestrained cytokine release. There is a crucial need to classify safe and active drugs for action. Chloroquine (CQ) exhibitions an inhibitory effect. However, the clinical use of CQ can cause severe side effects. Moreover, hydroxyl-chloroquine (HCQ) also exhibits an antiviral effect highly similar to that of CQ, inhibiting the cytokine storm by suppressing T-cell activation. Coronavirus vaccine will be carry after clinical trials ahead in markets.[Full Text Article]